The evaluation included variables such as age, gender, tumor location, TNM stage, T stage, lymph node metastasis, VALSG stage, and expression levels of TOP2A and CDK1. The gene discussed is CDK1; the disease is metastatic malignant neoplasm in the lymph nodes.